BACKGROUND: The adjusted 5-year survival for dialysis patients in the United States is 33%-35%, and patients treated with peritoneal dialysis (PD) have a high risk of transfer to hemodialysis (HD). No data are available on the effect of neighborhood characteristics or regional differences on the outcomes of PD patients in the United States. METHODS: We analyzed the relationships of selected patient demographics, socio-economic characteristics of the dialysis unit's neighborhood, "rurality," and geographic location with transfer to HD and with a composite outcome of transfer to HD or death, for all PD patients in the United States who, between 2004 and 2009, used supplies manufactured by Baxter Healthcare (n = 58 700). RESULTS: Over a median follow-up of 18.7 months, 29% of patients transferred to HD (median time to HD transfer: 49 months), and 54% reached the composite outcome. More than 20% of the events occurred within the first 90 days of PD start. The risk for each of the study outcomes was higher for patients who had received any previous treatment with HD, for those treated in units located in areas with a higher proportion of black residents, and for those living in remote rural areas. Furthermore, the risk for reaching either of the study outcomes was consistently lower for patients treated in units located in California, Alaska, Hawaii, Guam, the Mariana Islands, and American Samoa. CONCLUSIONS: We observed significant regional differences in the outcomes of PD patients in the United States that have not previously been reported. Understanding the differences in clinical practice that underlie these regional differences might help to further improve PD outcomes.
BACKGROUND: The adjusted 5-year survival for dialysis patients in the United States is 33%-35%, and patients treated with peritoneal dialysis (PD) have a high risk of transfer to hemodialysis (HD). No data are available on the effect of neighborhood characteristics or regional differences on the outcomes of PDpatients in the United States. METHODS: We analyzed the relationships of selected patient demographics, socio-economic characteristics of the dialysis unit's neighborhood, "rurality," and geographic location with transfer to HD and with a composite outcome of transfer to HD or death, for all PDpatients in the United States who, between 2004 and 2009, used supplies manufactured by Baxter Healthcare (n = 58 700). RESULTS: Over a median follow-up of 18.7 months, 29% of patients transferred to HD (median time to HD transfer: 49 months), and 54% reached the composite outcome. More than 20% of the events occurred within the first 90 days of PD start. The risk for each of the study outcomes was higher for patients who had received any previous treatment with HD, for those treated in units located in areas with a higher proportion of black residents, and for those living in remote rural areas. Furthermore, the risk for reaching either of the study outcomes was consistently lower for patients treated in units located in California, Alaska, Hawaii, Guam, the Mariana Islands, and American Samoa. CONCLUSIONS: We observed significant regional differences in the outcomes of PDpatients in the United States that have not previously been reported. Understanding the differences in clinical practice that underlie these regional differences might help to further improve PD outcomes.
Authors: Mala Chidambaram; Joanne M Bargman; Robert R Quinn; Peter C Austin; Janet E Hux; Andreas Laupacis Journal: Perit Dial Int Date: 2010-10-14 Impact factor: 1.756
Authors: Eric D Weinhandl; Robert N Foley; David T Gilbertson; Thomas J Arneson; Jon J Snyder; Allan J Collins Journal: J Am Soc Nephrol Date: 2010-02-04 Impact factor: 10.121
Authors: Rajnish Mehrotra; Osman Khawar; Uyen Duong; Linda Fried; Keith Norris; Allen Nissenson; Kamyar Kalantar-Zadeh Journal: Am J Kidney Dis Date: 2009-04-08 Impact factor: 8.860
Authors: Laura C Plantinga; Nancy E Fink; Fredric O Finkelstein; Neil R Powe; Bernard G Jaar Journal: Perit Dial Int Date: 2009 May-Jun Impact factor: 1.756
Authors: Takeshi Hasegawa; Jennifer L Bragg-Gresham; Shin Yamazaki; Shunichi Fukuhara; Tadao Akizawa; Werner Kleophas; Roger Greenwood; Ronald L Pisoni Journal: Clin J Am Soc Nephrol Date: 2009-03-04 Impact factor: 8.237
Authors: Suma Prakash; Rick Coffin; Jesse Schold; Steven A Lewis; Douglas Gunzler; Susan Stark; Matthew Howard; Darlene Rodgers; Douglas Einstadter; Ashwini R Sehgal Journal: Perit Dial Int Date: 2014 Jan-Feb Impact factor: 1.756
Authors: Yoshitsugu Obi; Elani Streja; Rajnish Mehrotra; Matthew B Rivara; Connie M Rhee; Melissa Soohoo; Daniel L Gillen; Wei-Ling Lau; Csaba P Kovesdy; Kamyar Kalantar-Zadeh Journal: Am J Kidney Dis Date: 2017-12-07 Impact factor: 8.860
Authors: Neil Boudville; David W Johnson; Junhui Zhao; Brian A Bieber; Ronald L Pisoni; Beth Piraino; Judith Bernardini; Sharon J Nessim; Yasuhiko Ito; Graham Woodrow; Fiona Brown; John Collins; Talerngsak Kanjanabuch; Cheuk-Chun Szeto; Jeffrey Perl Journal: Nephrol Dial Transplant Date: 2019-12-01 Impact factor: 5.992
Authors: Eric W Young; Alissa Kapke; Zhechen Ding; Regina Baker; Jeffrey Pearson; Chad Cogan; Purna Mukhopadhyay; Marc N Turenne Journal: Clin J Am Soc Nephrol Date: 2019-09-12 Impact factor: 8.237
Authors: Virginia Wang; Matthew L Maciejewski; Cynthia J Coffman; Linda L Sanders; Shoou-Yih Daniel Lee; Richard Hirth; Joseph Messana Journal: Health Serv Res Date: 2016-04-07 Impact factor: 3.402